Mucinous ovarian cancer

A descriptive report of outcomes of primary mucinous ovarian cancer patients receiving either an adjuvant gynecologic or gastrointestinal chemotherapy regimen
Brooke A Schlappe, Qin C Zhou, Roisin O'Cearbhaill, Alexia Iasonos, Robert A Soslow, Nadeem R Abu-Rustum, Jennifer J Mueller

International Journal of Gynecologic Cancer Jun 2019, 29 (5) 904-909; DOI: 10.1136/ijgc-2018-000150
Gynecologic Cancer InterGroup (GCIG) Consensus Review for Mucinous Ovarian Carcinoma
Jonathan A. Ledermann, Daniela Luvero, Aaron Shafer, Dennis O’Connor, Giorgia Mangili, Michael Friedlander, Jacobus Pfisterer, Mansoor R. Mirza, Jae-Weon Kim, Jerome Alexandre, Amit Oza, Jubilee Brown

International Journal of Gynecologic Cancer Nov 2014, 24 (Supp 3) S14-S19; DOI: 10.1097/IGC.0000000000000296
The N-Terminally Truncated p53 Isoform Δ40p53 Influences Prognosis in Mucinous Ovarian Cancer
Gerda Hofstetter, Astrid Berger, Regina Berger, Arijana Zorić, Elena I. Braicu, Daniel Reimer, Heidi Fiegl, Christian Marth, Alain G. Zeimet, Hanno Ulmer, Ute Moll, Robert Zeillinger, Nicole Concin

International Journal of Gynecologic Cancer Mar 2012, 22 (3) 372-379; DOI: 10.1097/IGC.0b013e31823ca031

Main menu